Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-28Social Support During a Randomized Trial of a Trucker Weight Loss Intervention
-
CLINICAL_TRIALS study results posted · 2026-10-27Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese
-
CLINICAL_TRIALS study results posted · 2026-10-26BARI-STEP:A Double-blinded, Randomised, Placebo-controlled Trial of Semaglutide 2.4 mg in Patients With Poor Weight-loss Following Bariatric Surgery.
-
CLINICAL_TRIALS study results posted · 2026-10-19Families Becoming Healthy Together
-
CLINICAL_TRIALS study results posted · 2026-10-19Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-10-14The Effects of Glucagon on Hepatic Metabolism
-
CLINICAL_TRIALS study results posted · 2026-10-14HealthMatters@24/7 Asynchronous Health Promotion eLearning for People Supporting Adults With Intellectual and Developmental Disabilities
-
CLINICAL_TRIALS study record update · 2026-10-14HealthMatters@24/7 Asynchronous Health Promotion eLearning for People Supporting Adults With Intellectual and Developmental Disabilities
-
CLINICAL_TRIALS study results posted · 2026-10-08Lifestyle Intervention in Preparation for Pregnancy (LIPP)
-
CLINICAL_TRIALS study results posted · 2026-10-07Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss: A Randomized Trial Using a Factorial Design
-
CLINICAL_TRIALS study record update · 2026-10-07Long-term Safety and Efficacy of Semaglutide s.c. Once-weekly on Weight Management in Children and Adolescents (Aged 6 to <18 Years) With Obesity or Overweight
-
CLINICAL_TRIALS study results posted · 2026-10-01Single-Center Prospective Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens
-
CLINICAL_TRIALS study record update · 2026-09-30Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study results posted · 2026-09-29A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTX3232 Alone or in Combination With Semaglutide in Participants With Obesity
-
CLINICAL_TRIALS study results posted · 2026-09-25Evaluation of Patient Coach Support for Older Adults With Obesity
-
CLINICAL_TRIALS study results posted · 2026-09-22Effects of Dietary Protein Intake and Resistance Training on Retention of Fat Free Mass During Weight Loss in Adults Over 50 With Obesity
-
CLINICAL_TRIALS study results posted · 2026-09-18Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management-Phase I
-
CLINICAL_TRIALS study record update · 2026-09-17A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study results posted · 2026-09-15The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology
-
CLINICAL_TRIALS study record update · 2026-09-09Long-term Safety and Efficacy of Semaglutide s.c. Once-weekly on Weight Management in Children and Adolescents (Aged 6 to <18 Years) With Obesity or Overweight
-
CLINICAL_TRIALS study results posted · 2026-09-04A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)
-
CLINICAL_TRIALS study record update · 2026-09-03A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study results posted · 2026-09-01Healthy Drinks, Healthy Futures: The Impact of a Childcare-based Healthy Beverages Intervention on Young Children's Food and Beverage Intake and Obesity
-
CLINICAL_TRIALS study results posted · 2026-08-31A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)
-
CLINICAL_TRIALS study record update · 2026-08-31Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity